Home
Solutions
Drug Development for Stroke
Development of Small Molecule Drug for Stroke
Targeted Stroke Drug Development
Stroke Drug Development Targeting Noncoding RNAs
Stroke Drug Development Targeting PSD-95
Stroke Drug Development Targeting Tau
Stroke Drug Development Targeting Heat Shock Protein 70
Stroke Drug Development Targeting Notch
Stroke Drug Development Targeting Guanosine
Stroke Drug Development Targeting Nogo-A
Stroke Drug Development Targeting Nrf2
Stroke Drug Development Targeting DAPK1
Stroke Drug Development Targeting AMPK
Stroke Drug Development Targeting Caveolin-1
Stroke Drug Development Targeting Cell Death
Stroke Drug Development Targeting Ferroptosis
Stroke Drug Development Targeting Pyroptosis
Stroke Drug Development Targeting Necroptosis
Stroke Drug Development Targeting Different Cell Types
Stroke Drug Development Targeting Astrocytes
Stroke Drug Development Targeting Microglia
Stroke Drug Development Targeting Other Components
Stroke Drug Development Targeting Mitochondria
Stroke Drug Development Targeting Autophagy
Stroke Drug Development Targeting Epigenetic Mechanisms
Stroke Drug Development Targeting Blood Brain Barrier
Stroke Drug Development Targeting Excitotoxicity
Stroke Drug Development Targeting NMDAR
Stroke Drug Development Targeting The GluN2B Subunit of NMDAR
Stroke Drug Development Targeting Glutamate
Development of Biologics for Stroke
Development of Stem Cellular Therapy for Stroke
Stroke Drug Development Targeting Gut Microbiota
Development of Therapeutic Antibodies for Stroke
Development of Exosome-Based Stroke Therapy
Development of UCHL1-Based Stroke Therapy
Development of Drug Delivery Systems for Stroke Treatment
Development of Nanoparticle Drug Delivery Systems for Stroke Treatment
Development of Liposome-Based Drug Delivery Systems for Stroke Treatment
Development of Exosomes Drug Delivery Systems for Stroke Treatment
Development of Stroke Diagnostic Technology
Development of Exosome-Based Stroke Diagnostic Technology
Development of RNA-Based Stroke Diagnostic Technology
Neuroimaging for Stroke Diagnosis
Pharmaceutical R&D Services
Preclinical CRO Services
ADME/DMPK Services for Stroke Drugs
High-Throughput ADME Screening Services for Stroke Drug Discovery and Development
In Vitro
ADME Services for Stroke Drug Discovery and Development
In Vivo
ADME Services for Stroke Drug Discovery and Development
PK/TK Analysis in Stroke Drug Discovery and Development
Trans-BBB PK Analysis in Stroke Drug Discovery and Development
PK/PD Analysis Service for Stroke Drug Discovery and Development
Bioanalytical Services for Stroke Drugs
Metabolite Identification and Profiling in Stroke Drug Discovery and Development
Neurochemistry Service in Stroke Drug Discovery & Development
Drug Efficacy Testing Services in Animal Models of Stroke
Cerebral Infarct Size Measurement Service in Animal Models of Stroke
Histological Assessment Service in Animal Models of Stroke
Physiological Monitoring Service in Animal Models of Stroke
Behavioral Testing Services in Animal Models of Stroke
Behavioral Assessment of Sensory in Animal Models of Stroke
Behavioral Assessment of Motor in Animal Models of Stroke
Behavioral Assessment of Cognition & Emotion in Animal Models of Stroke
Brain Imaging Services in Animal Models of Stroke
Fluorescence Imaging (FI) Service in Animal Models of Stroke
Bioluminescence Imaging (BLI) Service in Animal Models of Stroke
Magnetic Resonance Imaging (MRI) Service in Animal Models of Stroke
Photoacoustic Imaging (PAI) Service in Animal Models of Stroke
Laser Speckle Contrast Imaging (LSCI) Service in Animal Models of Stroke
Functional Ultrasound Imaging Service in Animal Models of Stroke
Micro-computed Tomography (Micro-CT) Imaging Service in Animal Models of Stroke
Positron Emission Tomography (PET) Imaging Service in Animal Models of Stroke
Single-photon Emission Computed Tomography (SPECT) Imaging Service in Animal Models of Stroke
Cerebral Blood Flow Monitoring Service in Animal Models of Stroke
Brain Edema Measurement Service in Animal Models of Stroke
Assessment of Blood-Brain Barrier Disruption in Stroke
Assessment of Leukocyte-Platelet Aggregates in Animal Models of Stroke
Quantitative Analysis of Stroke-related Protein and mRNA Expression
Safety Assessment Services for Stroke Drug Discovery & Development
Neurotoxicity Testing in Stroke Drug Discovery & Development
In Vitro
Pharmacology Services for Stroke Drugs
Cell Viability Assay Services for Stroke Drug Discovery & Development
Caspase-3 Activity Assay Services for Stroke Drug Discovery & Development
In Vitro
Neuroinflammatory Models and Assays in Stroke Drug Discovery & Development
Neurite Outgrowth Assay Services for Stroke Drug Discovery & Development
In Vitro
Microglial Function Assay Services for Stroke Drug Discovery & Development
Excitotoxicity In Vitro Assay Services for Stroke Drug Discovery & Development
Cell-Based Mitochondrial Function Assay Services for Stroke Drug Discovery
In Vitro
Oxidative Stress Assay Services for Stroke Drug Discovery & Development
Basic Research
Pathogenic Mechanism of Stroke
Exploration of the Role of Differential Targets in Stroke
Exploration of the Role of Cell Death in Stroke
Exploration of the Role of Different Cell Types in Stroke
Exploration of the Role of Other Components in Stroke
Customized Stroke Models
Animal Modeling of Stroke
In Vitro
Modeling of Stroke
Resources
What Is Stroke
Injury Mechanisms in Stroke
Current Drug Development Status for Stroke
Company
Contact Us
About Us
Careers
Search
Search
×
Home
Inquiry Basket
Cat. No.
Product Name
Qty
Delete selected
Online Inquiry
* Your Name
* Your Email
Phone
Project Description
Submit
0
Inquiry Basket
Delete selected
Check Out
Delete selected